Mineralocorticoid receptor
Showing 1 - 25 of 7,287
Primary Aldosteronism Trial in Montréal (Renin measurements)
Not yet recruiting
- Primary Aldosteronism
- Renin measurements
-
Montréal, Quebec, CanadaHôpital du Sacré-Coeur de Montréal
Oct 30, 2023
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
s to Learn More About Treatment With Steroidal Mineralocorticoid
Active, not recruiting
- Chronic Kidney Disease
- +2 more
- sMRA therapies
-
Whippany, New JerseyMany Locations
Jan 30, 2023
Chronic Kidney Disease, Albuminuria Trial in Birmingham (Spironolactone, Amiloride)
Completed
- Chronic Kidney Disease
- Albuminuria
-
Birmingham, AlabamaHypertension Research Clinic at UAB
Nov 21, 2022
Atherosclerosis Trial in Cleveland (Spironolactone, Placebo)
Completed
- Atherosclerosis
- Spironolactone
- Placebo
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Sep 16, 2022
Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical
Not yet recruiting
- Primary Hyperaldosteronism Due to Adrenal Adenoma
- Unilateral adrenalectomy
- Medical treatment (eplerenone)
-
Gothenburg, Sweden
- +2 more
Mar 30, 2023
Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)
Not yet recruiting
- Hypertension
- Left Ventricular Hypertrophy
- Eplerenone
- +2 more
- (no location specified)
Oct 26, 2022
Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Mineralocorticoid receptor antagonist
- Placebo
- (no location specified)
Sep 21, 2023
Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)
Recruiting
- Metabolic Syndrome
- +2 more
- Eplerenone
- Chlorthalidone with potassium chloride
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 28, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
Hypertension Trial in Ann Arbor (Placebo, Eplerenone 50mg)
Not yet recruiting
- Hypertension
- Placebo
- Eplerenone 50mg
-
Ann Arbor, MichiganUniversity of Michigan
Feb 4, 2022
Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Best Practice Alert
-
New Haven, ConnecticutCardiology/Internal Medicine Outpatient Clinics of Yale New Heal
Jan 17, 2022
Kidney Transplantation for More Than One Year, Patients With a Kidney Transplantation on Cyclosporine Trial in
Recruiting
- Kidney Transplantation for More Than One Year
- Patients With a Kidney Transplantation on Cyclosporine
- Eplerenone 50mg/day (cross over design)
- Period without eplerenone (cross over design)
-
Vandœuvre-lès-Nancy, FranceCHRU de Nancy
Aug 17, 2022
COVID-19 Pneumonia Trial in Szczecin (Canrenoate Potassium, Normal Saline)
Recruiting
- COVID-19 Pneumonia
- Canrenoate Potassium
- Normal Saline
-
Szczecin, PolandPomeranian Medical University
Jun 3, 2021
Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)
Recruiting
- Heart Failure
- Hyperkalemia
- Sodium zirconium cyclosilicate
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021
Primary Aldosteronism, Hypertension Trial (Eplerenone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Aug 26, 2021
STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction
- Dapagliflozin 10Mg Tab
- Placebo
- (no location specified)
Sep 6, 2021
Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
Recruiting
- Chronic Renal Failure
- Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
- Dapagliflozin 10mg Tab
- +5 more
-
Marseille, France
- +1 more
May 23, 2023
Hypotension, Heart Failure Trial in Taipei (Dapagliflozin, Sacubitril-Valsartan, Beta blocker)
Completed
- Hypotension
- Heart Failure
- Dapagliflozin
- +4 more
-
Taipei, TaiwanCheng Hsin General Hospital
Jul 27, 2021
Glucose Metabolism in Aldosterone-Producing Adenomas
Completed
- Primary Aldosteronism
- Adrenalectomy
- mineralocorticoid receptor antagonist
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 28, 2021
Major Depression Trial in Berlin (Placebo, Fludrocortisone, D-Cycloserine)
Completed
- Major Depression
- Placebo
- +2 more
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Jun 19, 2020
Heart Failure Trial in Worldwide (OPTIMIZER, Optimal medical therapy)
Terminated
- Heart Failure
- OPTIMIZER
- Optimal medical therapy
-
Graz, Austria
- +7 more
Sep 1, 2020